Evidence map›Paper›PMID 38773165›Full record

ArticleScientific reports2024

Development and characterization of a dedicated dose monitor for ultrahigh-dose-rate scanned carbon-ion beams.

Masashi Yagi, Shinichi Shimizu, Noriaki Hamatani, Takuto Miyoshi, Takuya Nomura, Takashi Toyoda, Mahoro Nakatani, Toshiro Tsubouchi, Masaki Shimizu, Yoshiaki Kuwana and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Masashi YagiDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Osaka, Japan. m.yagi@radonc.med.osaka-u.ac.jp.
Shinichi ShimizuDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
Noriaki HamataniDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Takuto MiyoshiHitachi, Ltd. Research & Development Group, Ibaraki, Japan.
Takuya NomuraHealthcare Business Division, Hitachi, Ltd, Chiba, Japan.
Takashi ToyodaHealthcare Business Division, Hitachi, Ltd, Chiba, Japan.
Mahoro NakataniMedical Physics Laboratory, Division of Health Science, Osaka University Graduate School of Medicine, Osaka, Japan.
Toshiro TsubouchiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Masaki ShimizuHealthcare Business Division, Hitachi, Ltd, Chiba, Japan.
Yoshiaki KuwanaHealthcare Business Division, Hitachi, Ltd, Chiba, Japan.
Masumi UmezawaHealthcare Business Division, Hitachi, Ltd, Chiba, Japan.
Masaaki TakashinaDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Teiji NishioMedical Physics Laboratory, Division of Health Science, Osaka University Graduate School of Medicine, Osaka, Japan.
Masahiko KoizumiDepartment of Medical Physics and Engineering, Graduate School of Medicine, Osaka, Japan.
Kazuhiko OgawaDepartment of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Tatsuaki KanaiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.

Funding

Japan Society for the Promotion of Science 22H03025Japan Society for the Promotion of Science 22K07695Japan Society for the Promotion of Science 22K07770
6 · The paper itself

Abstract

The current monochromatic beam mode (i.e., uHDR irradiation mode) of the scanned carbon-ion beam lacks a dedicated dose monitor, making the beam control challenging. We developed and characterized a dedicated dose monitor for uHDR-scanned carbon-ion beams. Furthermore, a simple measurable dose rate (dose rate per spot (DR

Identifiers

PMID38773165
PMCPMC11109334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.